Naohiko Inase

5.5k total citations · 1 hit paper
164 papers, 3.6k citations indexed

About

Naohiko Inase is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Physiology. According to data from OpenAlex, Naohiko Inase has authored 164 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Pulmonary and Respiratory Medicine, 29 papers in Public Health, Environmental and Occupational Health and 27 papers in Physiology. Recurrent topics in Naohiko Inase's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (73 papers), Occupational exposure and asthma (28 papers) and Inhalation and Respiratory Drug Delivery (19 papers). Naohiko Inase is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (73 papers), Occupational exposure and asthma (28 papers) and Inhalation and Respiratory Drug Delivery (19 papers). Naohiko Inase collaborates with scholars based in Japan, United States and Canada. Naohiko Inase's co-authors include Yasunari Miyazaki, Yasuyuki Yoshizawa, Yoshio Ohtani, Takumi Akashi, Shuji Miyake, Tomoya Tateishi, Yuki Sumi, Tamiko Takemura, Ken Uchibori and Haruhiko Furusawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Naohiko Inase

157 papers receiving 3.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer

2017 329 citations Ken Uchibori, Naohiko Inase et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Naohiko Inase Japan	31	2.5k	802	732	731	540	164	3.6k
Miguel Gaxiola Mexico	21	1.9k 0.8×	433 0.5×	279 0.4×	534 0.7×	264 0.5×	51	2.8k
Raphael Breuer Israel	31	1.9k 0.8×	564 0.7×	138 0.2×	409 0.6×	359 0.7×	113	3.1k
Naoki Hamada Japan	25	850 0.3×	473 0.6×	327 0.4×	206 0.3×	246 0.5×	105	2.2k
Laura L. Koth United States	29	3.2k 1.3×	720 0.9×	342 0.5×	3.1k 4.3×	244 0.5×	54	5.3k
Masaki Okamoto Japan	29	1.0k 0.4×	732 0.9×	157 0.2×	537 0.7×	236 0.4×	128	2.6k
Brett Ley United States	28	4.7k 1.9×	271 0.3×	631 0.9×	1.8k 2.4×	137 0.3×	48	5.1k
Kazuyoshi Kuwano Japan	26	1.8k 0.7×	761 0.9×	72 0.1×	963 1.3×	546 1.0×	80	3.0k
Holly Evanoff United States	27	926 0.4×	452 0.6×	135 0.2×	412 0.6×	753 1.4×	33	3.0k
Dmitri V. Pechkovsky Canada	24	1.2k 0.5×	575 0.7×	87 0.1×	568 0.8×	225 0.4×	32	2.3k
Elizabeth F. Redente United States	30	1.4k 0.6×	626 0.8×	99 0.1×	262 0.4×	330 0.6×	59	2.6k

Countries citing papers authored by Naohiko Inase

Since Specialization

Citations

This map shows the geographic impact of Naohiko Inase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naohiko Inase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naohiko Inase more than expected).

Fields of papers citing papers by Naohiko Inase

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naohiko Inase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naohiko Inase. The network helps show where Naohiko Inase may publish in the future.

Co-authorship network of co-authors of Naohiko Inase

This figure shows the co-authorship network connecting the top 25 collaborators of Naohiko Inase. A scholar is included among the top collaborators of Naohiko Inase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naohiko Inase. Naohiko Inase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sakashita, Hiroyuki, Ken Uchibori, Toshiharu Tsutsui, et al.. (2022). A phase II feasibility study of carboplatin and nab‐paclitaxel for advanced non‐small cell lung cancer patients with interstitial lung disease (YLOG0114). Thoracic Cancer. 13(9). 1267–1275. 3 indexed citations

Hisata, Shu, Masashi Bando, Sakae Homma, et al.. (2021). Safety and tolerability of combination therapy with pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A multicenter retrospective observational study in Japan. Respiratory Investigation. 59(6). 819–826. 17 indexed citations

Inoue, Yoshikazu, Takafumi Suda, Hideya Kitamura, et al.. (2021). Efficacy and safety of nintedanib in Japanese patients with progressive fibrosing interstitial lung diseases: Subgroup analysis of the randomised, double-blind, placebo-controlled, phase 3 INBUILD trial. Respiratory Medicine. 187. 106574–106574. 10 indexed citations

Uchibori, Ken, Naohiko Inase, Makoto Nishio, Naoya Fujita, & Ryohei Katayama. (2018). Identification of Mutation Accumulation as Resistance Mechanism Emerging in First-Line Osimertinib Treatment. Journal of Thoracic Oncology. 13(7). 915–925. 23 indexed citations

Miyoshi, Takao, Yoshio Ōtani, Yasunari Miyazaki, et al.. (2018). Can air purifier promote the indoor cleanliness and improve the patients with asthma?. PA1691–PA1691.

Tateishi, Tomoya, Tamiko Takemura, Yoshinori Okada, et al.. (2018). The Analysis of Surgical Lung Biopsy and Explanted Lung Specimens Sheds Light on the Pathological Progression of Chronic Bird-related Hypersensitivity Pneumonitis. Internal Medicine. 58(8). 1145–1150. 6 indexed citations

Honda, Takayuki, Hiroyuki Sakashita, Kyohei Masai, et al.. (2018). Deleterious Pulmonary Surfactant System Gene Mutations in Lung Adenocarcinomas Associated With Usual Interstitial Pneumonia. JCO Precision Oncology. 2(2). 1–24. 25 indexed citations

Uchibori, Ken, Naohiko Inase, Mitsugu Araki, et al.. (2017). Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer. Nature Communications. 8(1). 14768–14768. 329 indexed citations breakdown →

Sumi, Yuki, Tsukasa Okamoto, Tomoya Tateishi, et al.. (2014). The c-jun N-terminal kinase signaling pathway regulates airway smooth muscle cell proliferation. European Respiratory Journal. 44(Suppl 58). P3847–P3847. 2 indexed citations

10.

Uchibori, Ken, et al.. (2013). Esophageal bypass for the treatment of bronchoesophageal fistula in a case of squamous cell carcinoma of the lung. 35(2). 150–155.

11.

Furusawa, Haruhiko, Yasunari Miyazaki, Kimitake Tsuchiya, & Naohiko Inase. (2013). Three Cases of Sarcoidosis in Hypersensitivity Pneumonitis. 33(1). 127–132. 2 indexed citations

12.

Okamoto, Tsukasa, et al.. (2012). Proteome Analysis of Bronchoalveolar Lavage Fluid in Chronic Hypersensitivity Pneumonitis. Allergology International. 61(1). 83–92. 26 indexed citations

13.

Miyazaki, Yasunari, Masato Kishi, Takumi Akashi, et al.. (2010). The Pathogenesis of Chronic Hypersensitivity Pneumonitis in Common With Idiopathic Pulmonary Fibrosis. American Journal of Clinical Pathology. 134(4). 613–620. 36 indexed citations

14.

Takayama, Kōji, et al.. (2010). Clinical features of the 2009 swine-origin influenza A (H1N1) outbreak in Japan. Journal of Infection and Chemotherapy. 17(3). 401–406. 9 indexed citations

15.

Miyazaki, Yasunari, et al.. (2010). Th2-Biased Immune Responses Are Important in a Murine Model of Chronic Hypersensitivity Pneumonitis. International Archives of Allergy and Immunology. 154(3). 264–274. 33 indexed citations

16.

Sawada, Megumi, Naohiko Inase, Yoshio Ohtani, et al.. (2003). Chromosome 9p deletion in squamous metaplasia in cystic lesion of the lung. Respirology. 8(2). 239–242.

17.

Inase, Naohiko, et al.. (2003). Suicide gene therapy using keratin 19 enhancer and promoter in malignant mesothelioma cells.. PubMed. 23(2B). 1405–9. 4 indexed citations

18.

Ohtani, Yoshio, Kaoru Kojima, Yuki Sumi, et al.. (2000). Inhalation Provocation Tests in Chronic Bird Fancier's Lung. CHEST Journal. 118(5). 1382–1389. 106 indexed citations

19.

Tanaka, Michiko, Megumi Sawada, Naohiko Inase, et al.. (1999). Cases of Gingival Metastasis from Lung Cancer and a Review of the Literature.. Haigan. 39(3). 323–329. 8 indexed citations

20.

Inase, Naohiko, et al.. (1991). Pulmonary clear cell carcinoma. Journal of Surgical Oncology. 48(2). 145–147. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact